| 1 | ASAP2, MET
|
| ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma.
|
| Ma XL, Nie YY, Xie SH, Zheng H, Tong Y, Wang YC, Yan TQ, Meng X, Cao JZ, Tang WG, Guo L, Lu RQ.
|
| Exp Hematol Oncol. Apr 15;12(1):38. doi: 10.1186/s40164-023-00393-3. 2023
|
| 2 | DLC1, MET, TNS4, XPO1
|
| Identification of subcellular targeting sequences of Cten reveals its role in cell proliferation.
|
| Hong SY, Shih YP, Lo A, Lo SH.
|
| Biochim Biophys Acta Mol Cell Res 1866(3):450-458. doi: 10.1016/j.bbamcr.2018.10.008. Epub 2018 Oct 13.
2019
|
| 3 | ANKRD22, ARNTL2, CEP55, COL17A1, ITGB6, KLK10, MCOLN3, MET, SLC25A45
|
| Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer
|
| Wu M, Li X, Zhang T, Liu Z, Zhao Y.
|
| Front Oncol. Sep 27;9:996. doi: 10.3389/fonc.2019.00996 2019
|
| 4 | DYRK1A, MET
|
| DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth
|
| Luna J, Boni J, Cuatrecasas M, Bofill-De Ros X, Núńez-Manchón E, Gironella M, Vaquero EC, Arbones ML, de la Luna S, Fillat C.
|
| Gut Aug;68(8):1465-1476. doi: 10.1136/gutjnl-2018-316128. Epub 2018 Oct 20. 2019
|
| 5 | EGRF, ERBB2, MET, PLXNB1, SEMA3C
|
| SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.
|
| Peacock JW, Takeuchi A, Hayashi N, Liu L, Tam KJ, Al Nakouzi N, Khazamipour N, Tombe T, Dejima T, Lee KC, Shiota M, Thaper D, Lee WC, Hui DH, Kuruma H, Ivanova L, Yenki P, Jiao IZ, Khosravi S, Mui AL, Fazli L, Zoubeidi A, Daugaard M, Gleave ME, Ong CJ.
|
| EMBO Mol Med 10(2):219-238. doi: 10.15252/emmm.201707689.
2018
|
| 6 | MET, USP8
|
| USP8/UBPy-regulated sorting and the development of sperm acrosome: the recruitment of MET.
|
| Berruti G, Paiardi C.
|
| Reproduction eproduction. 2015 Mar 5. pii: REP-14-0671. [Epub ahead of print]
2015
|
| 7 | MET, OFSD
|
| Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.
|
| Gray MJ, Kannu P, Sharma S, Neyt C, Zhang D, Paria N, Daniel PB, Whetstone H, Sprenger HG, Hammerschmidt P, Weng A, Dupuis L, Jobling R, Mendoza-Londono R, Dray M, Su P, Wilson MJ, Kapur RP, McCarthy EF, Alman BA, Howard A, Somers GR, Marshall CR, Manners S, Flanagan AM, Rathjen KE, Karol LA, Crawford H, Markie DM, Rios JJ, Wise CA, Robertson SP.
|
| Am J Hum Genet 97(6):837-47. doi: 10.1016/j.ajhg.2015.11.001.
2015
|
| 8 | MC1R, MET
|
| A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma.
|
| Wolnicka-Glubisz A, Strickland FM, Wielgus A, Anver M, Merlino G, De Fabo EC, Noonan FP.
|
| Int J Cancer 136(4):752-60. doi: 10.1002/ijc.29050. Epub 2014 Jul 7.
2015
|
| 9 | DFNB97, MET
|
| A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.
|
| Mujtaba G, Schultz JM, Imtiaz A, Morell RJ, Friedman TB, Naz S.
|
| J Med Genet. Aug;52(8):548-52. doi: 10.1136/jmedgenet-2015-103023. Epub 2015 May 4. 2015
|
| 10 | MET, PIM1
|
| The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling.
|
| Cen B, Xiong Y, Song JH, Mahajan S, DuPont R, McEachern K, DeAngelo DJ, Cortes JE, Minden MD, Ebens A, Mims A, LaRue AC, Kraft AS.
|
| Mol Cell Biol 34(13):2517-32. doi: 10.1128/MCB.00147-14. Epub 2014 Apr 28.
2014
|
| 11 | CASP3, MET
|
| Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes.
|
| Ma J, Zou C, Guo L, Seneviratne DS, Tan X, Kwon YK, An J, Bowser R, DeFrances MC, Zarnegar R.
|
| Hepatology 59(5):2010-21. doi: 10.1002/hep.26769. Epub 2014 Apr 1.
2014
|
| 12 | LRIG1, MET, USP8
|
| USP8 modulates ubiquitination of LRIG1 for Met degradation.
|
| Oh YM, Lee SB, Choi J, Suh HY, Shim S, Song YJ, Kim B, Lee JM, Oh SJ, Jeong Y, Cheong KH, Song PH, Kim KA.
|
| Sci Rep 4:4980. doi: 10.1038/srep04980.
2014
|
| 13 | MET, MSTN, SMYD3
|
| The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.
|
| Proserpio V, Fittipaldi R, Ryall JG, Sartorelli V, Caretti G.
|
| Genes Dev 27(11):1299-312. doi: 10.1101/gad.217240.113.
2013
|
| 14 | MET, SNX1, SNX2
|
| Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugs.
|
| Ogi S, Fujita H, Kashihara M, Yamamoto C, Sonoda K, Okamoto I, Nakagawa K, Ohdo S, Tanaka Y, Kuwano M, Ono M.
|
| Cancer Sci 104(5):573-83. doi: 10.1111/cas.12117. Epub 2013 Mar 8. 2013
|
| 15 | MET, OVOL1, OVOL2
|
| Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
|
| Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton S, Healy PN, Pienta KJ.
|
| PLoS One 8(10):e76773. doi: 10.1371/journal.pone.0076773. eCollection 2013.
2013
|
| 16 | MET, MUC1
|
| MUC1 drives c-Met-dependent migration and scattering.
|
| Horm TM, Bitler BG, Broka DM, Louderbough JM, Schroeder JA.
|
| Mol Cancer Res 10(12):1544-54. doi: 10.1158/1541-7786.MCR-12-0296. Epub 2012 Nov 27.
2012
|
| 17 | MET, PLXNB1, SEMA4D
|
| Sema4D, the ligand for Plexin B1, suppresses c-Met activation and migration and promotes melanocyte survival and growth.
|
| Soong J, Chen Y, Shustef EM, Scott GA.
|
| J Invest Dermatol 132(4):1230-8. doi: 10.1038/jid.2011.414. Epub 2011 Dec 22.
2012
|
| 18 | LRRK2, MET
|
| Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
|
| Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ, West AB, Resau JH, Teh BT, MacKeigan JP.
|
| Proc Natl Acad Sci U S A 108(4):1439-44. Epub 2011 Jan 10.
2011
|
| 19 | FOXP2, MET
|
| Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk.
|
| Mukamel Z, Konopka G, Wexler E, Osborn GE, Dong H, Bergman MY, Levitt P, Geschwind DH.
|
| J Neurosci 31(32):11437-42.
2011
|
| 20 | MET
|
| Wild-type p53 controls cell motility and invasion by dual regulation of MET expression.
|
| Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Körner S, Wang W, Boccaccio C, Thorgeirsson SS, Comoglio PM, Hermeking H, Nikitin AY.
|
| Proc Natl Acad Sci U S A 108(34):14240-5. Epub 2011 Aug 9.
2011
|
| 21 | MET, SOX2
|
| Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.
|
| Cai YR, Zhang HQ, Qu Y, Mu J, Zhao D, Zhou LJ, Yan H, Ye JW, Liu Y.
|
| Oncol Rep 26(4):877-85. doi: 10.3892/or.2011.1349. Epub 2011 Jun 15.
2011
|
| 22 | MET
|
| A direct role for Met endocytosis in tumorigenesis.
|
| Joffre C, Barrow R, Ménard L, Calleja V, Hart IR, Kermorgant S.
|
| Nat Cell Biol 13(7):827-37. doi: 10.1038/ncb2257.
2011
|
| 23 | EGFR, MET
|
| Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells.
|
| Xu H, Stabile LP, Gubish CT, Gooding WE, Grandis JR, Siegfried JM.
|
| Clin Cancer Res 17(13):4425-38. Epub 2011 May 27.
2011
|
| 24 | MET
|
| Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient.
|
| Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O.
|
| Mod Pathol 24(8):1146-55. doi: 10.1038/modpathol.2011.70. Epub 2011 Apr 8.
2011
|
| 25 | MET
|
| MET mutations in cancers of unknown primary origin (CUPs).
|
| Stella GM, Benvenuti S, Gramaglia D, Scarpa A, Tomezzoli A, Cassoni P, Senetta R, Venesio T, Pozzi E, Bardelli A, Comoglio PM.
|
| Hum Mutat 32(1):44-50. doi: 10.1002/humu.21374. Epub 2010 Nov 9.
2011
|
| 26 | HGF, IL11, MET
|
| Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F.
|
| Boissinot M, Cleyrat C, Vilaine M, Jacques Y, Corre I, Hermouet S.
|
| Oncogene 30(8):990-1001. Epub 2010 Nov 1.
2011
|
| 27 | FOXP2, MET
|
| Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk.
|
| Mukamel Z, Konopka G, Wexler E, Osborn GE, Dong H, Bergman MY, Levitt P, Geschwind DH.
|
| J Neurosci. 31(32):11437-42. 2011
|
| 28 | MET
|
| The C-terminus of Hsp70-interacting protein promotes Met receptor degradation.
|
| Jang KW, Lee JE, Kim SY, Kang MW, Na MH, Lee CS, Song KS, Lim SP.
|
| J Thorac Oncol. 6(4):679-87. 2011
|
| 29 | MET
|
| Efficacy of c-Met inhibitor for advanced prostate cancer.
|
| Tu WH, Zhu C, Clark C, Christensen JG, Sun Z.
|
| BMC Cancer 10:556.
2010
|
| 30 | MET
|
| Further evidence for the role of MET in autism susceptibility.
|
| Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, Tsuchiya KJ, Anitha A, Iwayama Y, Yamada K, Hattori E, Matsuzaki H, Matsumoto K, Iwata Y, Suzuki K, Suda S, Kawai M, Sugihara G, Takebayashi K, Takei N, Ichikawa H, Sugiyama T, Yoshikawa T, Mori N.
|
| Neurosci Res 68(2):137-41. Epub 2010 Jul 6.
2010
|
| 31 | MET
|
| Hepatocyte growth factor receptor, c-Met, in human embryo salivary glands. An immunohistochemical study.
|
| Loreto C, Caltabiano R, Musumeci G, Caltabiano C, Greco MG, Leonardi R.
|
| Anat Histol Embryol 39(3):173-7. Epub 2010 Mar 22.
2010
|
| 32 | FH, MET
|
| Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.
|
| Costa B, Dettori D, Lorenzato A, Bardella C, Coltella N, Martino C, Cammarata C, Carmeliet P, Olivero M, Di Renzo MF.
|
| FASEB J 24(8):2680-8. Epub 2010 Mar 30.
2010
|
| 33 | MACC1, MET
|
| MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.
|
| Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM.
|
| Nat Med 15(1):59-67. Epub 2008 Dec 21. 2009
|
| 34 | MET
|
| MET and autism susceptibility: family and case-control studies.
|
| Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, Sykes NH, Lamb JA, Bailey AJ, Battaglia A, Maestrini E, Monaco AP; International Molecular Genetic Study of Autism Consortium (IMGSAC).
|
| Eur J Hum Genet 17(6):749-58. Epub 2008 Nov 12.
2009
|
| 35 | MET
|
| The function, proteolytic processing, and histopathology of Met in cancer.
|
| Hanna JA, Bordeaux J, Rimm DL, Agarwal S.
|
| Adv Cancer Res 103:1-23. Review.
2009
|
| 36 | MET
|
| cMET and refractive error progression in children.
|
| Khor CC, Grignani R, Ng DP, Toh KY, Chia KS, Tan D, Goh DL, Saw SM.
|
| Ophthalmology 116(8):1469-74, 1474.e1. Epub 2009 Jun 4.
2009
|
| 37 | MET
|
| Decorin is a novel antagonistic ligand of the Met receptor.
|
| Goldoni S, Humphries A, Nyström A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV.
|
| J Cell Biol. 185(4):743-54. 2009
|
| 38 | AUTS9, MET
|
| MET and autism susceptibility: family and case-control studies.
|
| Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, Sykes NH, Lamb JA, Bailey AJ, Battaglia A, Maestrini E, Monaco AP.
|
| Eur J Hum Genet ur J Hum Genet. 2008 Nov 12. [Epub ahead of print] 2008
|
| 39 | AUTS9, MET
|
| Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder.
|
| Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P.
|
| Autism Res 1(3):159-68.
2008
|
| 40 | MET
|
| Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation.
|
| Sheth PR, Hays JL, Elferink LA, Watowich SJ.
|
| Biochemistry 47(13):4028-38. Epub 2008 Mar 7.PMID: 18324780 2008
|
| 41 | LRIG1, MET
|
| LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.
|
| Shattuck DL, Miller JK, Laederich M, Funes M, Petersen H, Carraway KL 3rd, Sweeney C.
|
| Mol Cell Biol 27(5):1934-46. Epub 2006 Dec 18.
2007
|
| 42 | HPRC, MET
|
| Common pattern of unusual chromosome abnormalities in hereditary papillary renal carcinoma.
|
| Prat E, Bernues M, Del Rey J, Camps J, Ponsa I, Algaba F, Egozcue J, Caballin MR, Gelabert A, Miro R.
|
| Cancer Genet Cytogenet 164(2):142-7. 2006
|
| 43 | MET
|
| A genetic variant that disrupts MET transcription is associated with autism.
|
| Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P.
|
| Proc Natl Acad Sci U S A 103(45):16834-9. Epub 2006 Oct 19. 2006
|
| 44 | AUTS9, MET
|
| A genetic variant that disrupts MET transcription is associated with autism.
|
| Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P.
|
| Proc Natl Acad Sci U S A 103(45):16834-9. Epub 2006 Oct 19.
2006
|
| 45 | MET, SPSB1
|
| The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.
|
| Wang D, Li Z, Messing EM, Wu G.
|
| J Biol Chem 280(16):16393-401. Epub 2005 Feb 15. 2005
|
| 46 | MET
|
| The SH2-domian-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading.
|
| Koch A, Mancini A, El Bounkari O, Tamura T.
|
| Oncogene. 24(21):3436-47. 2005
|
| 47 | MET
|
| Novel interaction partners of the TPR/MET tyrosine kinase.
|
| Schaaf CP, Benzing J, Schmitt T, Erz DH, Tewes M, Bartram CR, Janssen JW.
|
| FASEB J. 19(2):267-9. 2005
|
| 48 | HPRC, MET
|
| Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
|
| Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Berez V, Borras J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM.
|
| J Urol 172(4 Pt 1):1256-61. 2004
|
| 49 | MET, RANBP10, RANBP9
|
| A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling.
|
| Wang D, Li Z, Schoen SR, Messing EM, Wu G.
|
| Biochem Biophys Res Commun 313(2):320-6. 2004
|
| 50 | MET
|
| Inhibition by copper(II) binding of hepatocyte growth factor (HGF) interaction with its receptor Met and blockade of HGF/Met function.
|
| Wright TG, Tsai J, Jia Z, Elliott BE.
|
| J Biol Chem. 279(31):32499-506. 2004
|
| 51 | MET
|
| MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.
|
| Higuchi T, Orita T, Katsuya K, Yamasaki Y, Akiyama K, Li H, Yamamoto T, Saito Y, Nakamura M.
|
| Mol Cell Biol. 24(17):7456-68. 2004
|
| 52 | BHD, FPTC, HLRCC, MET
|
| Familial adult renal neoplasia.
|
| Takahashi M, Kahnoski R, Gross D, Nicol D, Teh BT.
|
| J Med Genet 39(1):1-5. Review. 2002
|
| 53 | MET
|
| Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
|
| Lorenzato A, Olivero M, Patane S, Rosso E, Oliaro A, Comoglio PM, Di Renzo MF.
|
| Cancer Res 62(23):7025-30. 2002
|
| 54 | MET
|
| The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.
|
| Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S.
|
| Nature. 416(6877):187-90. 2002
|
| 55 | MET
|
| Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
|
| Monga SP, Mars WM, Pediaditakis P, Bell A, Mulé K, Bowen WC, Wang X, Zarnegar R, Michalopoulos GK.
|
| Cancer Res. 62(7):2064-71. 2002
|
| 56 | MET
|
| The semaphorin 4D receptor controls invasive growth by coupling with Met.
|
| Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, Barberis D, Tamagnone L, Comoglio PM.
|
| Nat Cell Biol. 4(9):720-4. 2002
|
| 57 | MET
|
| Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM.
|
| Wang D, Li Z, Messing EM, Wu G.
|
| J Biol Chem. 277(39):36216-22. 2002
|
| 58 | MET
|
| Ligand-regulated binding of FAP68 to the hepatocyte growth factor receptor.
|
| Grisendi S, Chambraud B, Gout I, Comoglio PM, Crepaldi T.
|
| J Biol Chem. 276(49):46632-8. 2001
|
| 59 | MET
|
| A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.
|
| Trusolino L, Bertotti A, Comoglio PM.
|
| Cell. 107(5):643-54. 2001
|
| 60 | MET
|
| HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells.
|
| Davies G, Jiang WG, Mason MD.
|
| Int J Mol Med. 7(4):385-8. 2001
|
| 61 | MET
|
| Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene.
|
| Glukhova L, Lavialle C, Fauvet D, Chudoba I, Danglot G, Angevin E, Bernheim A, Goguel AF.
|
| Oncogene 19(6):754-61. 2000
|
| 62 | MET
|
| Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses.
|
| Schaeper U, Gehring NH, Fuchs KP, Sachs M, Kempkes B, Birchmeier W.
|
| J Cell Biol. 149(7):1419-32. 2000
|
| 63 | MET
|
| Cross-talk between the proto-oncogenes Met and Ron.
|
| Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM.
|
| Oncogene. 19(27):3041-9. 2000
|
| 64 | MET
|
| Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas.
|
| Park WS, et al.
|
| Cancer Res 59(2):307-10. 1999
|
| 65 | MET, HPRC
|
| Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
|
| Schmidt L, et al.
|
| Oncogene 18(14):2343-50. 1999
|
| 66 | HPRC, MET
|
| Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.
|
| Olivero M, et al.
|
| Int J Cancer 82(5):640-3 1999
|
| 67 | HPRC, MET
|
| Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas.
|
| Zhuang Z, et al.
|
| Nat Genet 20 : 66-69. 1998
|
| 68 | MET
|
| The human hepatocyte growth factor receptor gene : complete structural organization and promoter characterization.
|
| Liu Y.
|
| Gene 215 : 159-169. 1998
|
| 69 | MET
|
| c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
|
| Rahimi N, Hung W, Tremblay E, Saulnier R, Elliott B.
|
| J Biol Chem. 273(50):33714-21. 1998
|
| 70 | MET, HPRC
|
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
|
| Schmidt L, et al.
|
| Nat Genet 16 : 68-73. 1997
|
| 71 | CAPZA2, MET
|
| Identification of an amplified gene cluster in glioma including two novel amplified genes isolated by exon trapping.
|
| Mueller HW, Michel A, Heckel D, Fischer U, Tonnes M, Tsui LC, Scherer S, Zang KD, Meese E.
|
| Hum Genet 101(2):190-7. 1997
|
| 72 | MET
|
| Gene structure of the human MET proto-oncogene.
|
| Duh FM, Scherer SW, Tsui LC, Lerman MI, Zbar B, Schmidt L.
|
| Oncogene 15(13):1583-6. 1997
|
| 73 | MET, ST7
|
| Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
|
| Lin JC, et al.
|
| Oncogene 13 : 2001-2008. 1996
|
| 74 | BAG1, MET
|
| HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death.
|
| Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C, Comoglio PM.
|
| EMBO J 15(22):6205-12 1996
|
| 75 | MET
|
| Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development.
|
| Maina F, Casagranda F, Audero E, Simeone A, Comoglio PM, Klein R, Ponzetto C.
|
| Cell. 87(3):531-42. 1996
|
| 76 | MET
|
| The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein.
|
| Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfield MD, Ponzetto C, Pelicci PG, et al.
|
| Oncogene. 10(8):1631-8. 1995
|
| 77 | MET
|
| Expression of c-met proto-oncogene in COS cells induces the signal transducing high-affinity receptor for hepatocyte growth factor.
|
| Higuchi O, et al.
|
| FEBS Lett 301 : 282-286. 1992
|
| 78 | MET
|
| The met oncogene : from detection by transfection to transmembrane receptor for hepatocyte growth factor.
|
| Cooper CS.
|
| Oncogene 7 : 3-7. 1992
|
| 79 | MET
|
| c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
|
| Ponzetto C, et al.
|
| Oncogene 6 : 553-559. 1991
|
| 80 | MET
|
| Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.
|
| Bottaro DP, et al.
|
| Science 251 : 802-804. 1991
|
| 81 | MET
|
| Tyrosine kinase receptor indistinguishable from the c-met protein.
|
| Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM.
|
| Nature 339 : 155-156. 1989
|
| 82 | MET
|
| Detection of a Notl polymorphism with the pmetH probe by pulsed-field gel electrophoresis.
|
| Julier C, et al.
|
| Am J Hum Genet 42 : 45-48. 1988
|
| 83 | MET
|
| Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to others markers tightly linked to the cystic fibrosis locus.
|
| Park M, et al.
|
| Proc Natl Acad Sci U S A 85 : 2667-2671. 1988
|
| 84 | COL1A2, CPA1, MET, PRSS1
|
| Regional localization of probes on human chromosome 7q.
|
| Naylor SL, et al.
|
| (HGM9) Cytogenet Cell Genet 46 : 669. 1987
|
| 85 | CFTR, MET, ABCB1, ABCB4
|
| Mapping of DNA markers linked to the cystic fibrosis locus on the long arm of chromosome 7.
|
| Zengerling S, et al.
|
| Am J Hum Genet 40 : 228-236. 1987
|
| 86 | MET
|
| Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.
|
| Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G.
|
| Proc Natl Acad Sci U S A. 84(18):6379-83. 1987
|
| 87 | MET
|
| The activated human met gene encodes a protein tyrosine kinase.
|
| Tempest PR, et al.
|
| FEBS Lett 209 : 357-361. 1986
|
| 88 | CFTR, MET, D7S8
|
| Linkage of cystic fibrosis to two tightly linked DNA markers : Joint report from a collaborative study.
|
| Beaudet A, et al.
|
| Am J Hum Genet 39 : 681-693. 1986
|
| 89 | MET
|
| Homogeneity of cystic fibrosis in Italy.
|
| Vitale E, et al.
|
| Am J Hum Genet 39 : 832-836. 1986
|
| 90 | MET, D7S449
|
| The human met oncogene is related to the tyrosine kinase oncogenes.
|
| Dean M, et al.
|
| Nature 318 : 385-388. 1985
|